The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real-world Clinical Setting

OBJECTIVE: Schizophrenia is a debilitating disease that disrupts the lives of many affected individuals and exerts a toll on the health system. Only few studies assessed once-monthly injectable formulation of paliperidone palmitate (PP-1M) and other long-acting antipsychotics in recent onset schizop...

Descripción completa

Detalles Bibliográficos
Autores principales: Peitl, Vjekoslav, Margetić, Branka Aukst, Vidrih, Branka, Karlović, Dalibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813319/
https://www.ncbi.nlm.nih.gov/pubmed/35078954
http://dx.doi.org/10.9758/cpn.2022.20.1.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813319/
https://www.ncbi.nlm.nih.gov/pubmed/35078954
http://dx.doi.org/10.9758/cpn.2022.20.1.118

Ejemplares similares